Find a Doctor or Practice Location

Are you a referring physician?
within
I am searching for a
Reset Form
Christopher D. Watt, MD, PhD

Christopher D. Watt, MD, PhD Physician

Associate Director, Molecular Pathology Laboratory
Assistant Professor of Clinical Pathology and Laboratory Medicine
No Patient Satisfaction Reviews
Why not?

There is no publicly available rating for this medical professional for one of the following reasons:

  1. He or she sees patients but has not yet received the minimum number of Patient Satisfaction Reviews.
  2. He or she does not see patients.
  3. He or she is not employed by Penn Medicine.

To be eligible for display, we require a minimum of 30 surveys returned in the past 12 months. This ensures that the rating is statistically reliable and a true reflection of patient satisfaction.

X

Dr. Watt is a Penn Medicine employed physician.

Clinical Specialties

Specialty:

  • Pathology and Laboratory Medicine

Programs & Centers:

  • Molecular and Genomic Pathology

Board Certification:

  • Pathology - Clinical Pathology, 2008
  • Pathology - Molecular Genetic Pathology, 2009

Description of Clinical Expertise

Molecular Pathology

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • CVS Health
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan

Education and Training

Medical School: University of Pennsylvania School of Medicine
Residency: Hospital of the University of Pennsylvania
Fellowship: Hospital of the University of Pennsylvania

Memberships

American Medical Association, Member, National American Society for Clinical Pathology, Fellow Member, International Association for Molecular Pathology, Associate Member, International College of American Pathologists, Fellow Member, International

Hospital Affiliation

Dr. Watt is a Penn Medicine employed physician.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.

Research

Selected Publications:

Nybakken G, Canaani J, Darshan R, Morrissette J, Watt CD, Shah N, Smith C, Bagg A, Carroll M, and Perl A: Quizartinib elicits differential responses that correlate with karyotype and genotype of the leukemic clone. Leukemia 30 (6): 1422-5,2016.

Canaani J, Rea B, Sargent R, Morrissette J, Lieberman D, Watt CD, Carroll M, Perl A: Differentiation response to gilteritinib (ASP2215) in relapsed/refractory FLT3 mutated acute myeloid leukemia patients is associated with co-mutations in NPM1 and DNMT3A. Haematologica 101 (S1): 2016.

Hiemenz MC, Kadauke S, Lieberman DB, Roth DB, Zhao J, Watt CD, Daber RD, Morrissette JJ: Building a robust tumor profiling program: Synergy between next-generation sequencing and targeted single-gene testing. PLoS One 11 (4): 2016.

Cambor C, Roth D, Loundas C, Heuer M, Watt C, Montone K, Sesok-Pizzini D: Development of a dynamic leadership curriculum to enhance residency education in pathology and laboratory medicine. Modern Pathology 29 (S2): 2016.

Surrey LF, Smith JR, Lubin D, Van Deerlin V, Watt CD: Analytic Approach for Complete and Mixed Engraftment Analysis using Commercial Software. The Journal of Molecular Diagnostics : 2016.

Li Y, Alby K, Watt CD, Roth JJ: Integration of Rapid Molecular Testing for Influenza and RSV into Existing Diagnostic Workflow. The Journal of Molecular Diagnostics : 2016.

Press RD, Watt CD, Cai L, Van Deerlin VM, Roth JJ, Gentile C, Loren A, and Eickelberg G: BCR-ABL1 molecular responses at 12-18 months predict long-term event-free survival in patients with tyrosine kinase inhibitor (TKI)-treated chronic myelogenous leukemia (CML). The Journal of Molecular Diagnostics : 2016.

Roth JJ, Windon AL, Strubinger J, Carlin A, Gentile C, Watt CD, McGrath CM, Van Deerlin VM: Improvements in workflow after verification and implementation of the cobas® HPV Test. The Journal of Molecular Diagnostics : 2016.

Roth JJ, Gentile CS, Sayer D, Nielsen D, Van Deerlin VM, Alby KA, and Watt CD: Evaluation of the Roche Cobas Liat influenza A/B assay: the effects of Liat implementation in the clinical laboratory and a comparison of results to a laboratory developed real-time PCR assay. The Journal of Molecular Diagnostics 17 (6): 784,2015.

Luskin MR, Huen AO, Brooks S, Stewart C, Watt CD, Morrissette J, Lieberman DB, Bagg A, Rosenbach M, Perl AE: NPM1 mutation is associated with leukemia cutis in acute myeloid leukemia with monocytic features. Haematologica 100 (10): e412-414,2015.

Academic Contact Info

Department of Pathology and Laboratory Medicine
Hospital of the University of Pennsylvania
3400 Spruce Street

Philadelphia, PA 19104